Anna Maria Werling
Biographic Data
| ID | 7906255 |
|---|---|
| NAME | Anna Maria Werling |
| GIVEN NAMES | Anna Maria |
| FAMILY NAME | Werling |
| SIGNATURE | WERLING A M |
| AFFILIATIONS | University of Zurich |
| ORCID | 0000-0001-8998-7902 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD
Current findings indicate a potential value of self-report (BRIEF global score) and some objectively measured neurocognitive indices (CPT commission errors and hit reaction time variability) as treatment markers (of change) for MPH. However, we found a rather limited prognostic value with regard to predicting treatment response not (yet) allowing recommendation for clinical use. Baseline symptom severity was revealed as the most relevant predicto…
Problematic use of digital media in children and adolescents with a diagnosis of attention-deficit/hyperactivity disorder compared to controls. A meta-analysis
Personalized at‐home neurofeedback compared to long‐acting methylphenidate in children with ADHD
BACKGROUND: Neurofeedback is considered a promising intervention for the treatment of attention-deficit hyperactivity disorder (ADHD). NEWROFEED is a prospective, multicentre, randomized (3:2), reference drug-controlled trial in children with ADHD aged between 7 and 13 years. The main objective of NEWROFEED was to demonstrate the noninferiority of personalized at-home neurofeedback (NF) training versus methylphenidate in the treatment of children…
The Impact of the Covid-19 Pandemic on Mental Health Care of Children and Adolescents in Switzerland
For the first pandemic year, youth mental health professionals reported a large increase in the treatment demand and waiting time and a worrisome overload of treatment services
No prominent works on this page.
Problematic use of digital media in children and adolescents with a diagnosis of attention-deficit/hyperactivity disorder compared to controls. A meta-analysis
Personalized at‐home neurofeedback compared to long‐acting methylphenidate in children with ADHD
BACKGROUND: Neurofeedback is considered a promising intervention for the treatment of attention-deficit hyperactivity disorder (ADHD). NEWROFEED is a prospective, multicentre, randomized (3:2), reference drug-controlled trial in children with ADHD aged between 7 and 13 years. The main objective of NEWROFEED was to demonstrate the noninferiority of personalized at-home neurofeedback (NF) training versus methylphenidate in the treatment of children…
The Impact of the Covid-19 Pandemic on Mental Health Care of Children and Adolescents in Switzerland
For the first pandemic year, youth mental health professionals reported a large increase in the treatment demand and waiting time and a worrisome overload of treatment services
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD
Current findings indicate a potential value of self-report (BRIEF global score) and some objectively measured neurocognitive indices (CPT commission errors and hit reaction time variability) as treatment markers (of change) for MPH. However, we found a rather limited prognostic value with regard to predicting treatment response not (yet) allowing recommendation for clinical use. Baseline symptom severity was revealed as the most relevant predicto…
Medicine (3 works) · Psychiatry (3 works) · Psychology (3 works) · Attention Deficit Hyperactivity Disorder (2 works) · Electroencephalography (2 works) · Internal Medicine (2 works) · Methylphenidate (2 works) · Neural and Behavioral Psychology Studies (2 works) · Neurofeedback (2 works) · Child and Adolescent Psychosocial and Emotional Development (1 work)